Increasing evidence suggests that carbohydrate-binding proteins play an ess
ential role in tumor growth and metastasis. However, conflicting results on
their function in the regulation of cell proliferation and differentiation
during angiogenesis have been reported. We have examined the role of galec
tin-3 in the regulation of human umbilical vein endothelial cell proliferat
ion, differentiation, migration, and neovascularization. Galectin-3, a carb
ohydrate-binding protein, with specificity for type 1 and 11 ABH blood grou
p epitopes and polylactosamine glycan containing cell surface glycoproteins
, is the major nonintegrin-cellular laminin-binding protein. Because galect
in-3 expression was shown to be associated in some tumor systems with metas
tasis, we questioned whether it induces endothelial cell morphogenesis. Her
e we show that galectin-3 affects chemotaxis and morphology and stimulates
capillary tube formation of HUV-EC-C in vitro and angiogenesis in vivo. End
othelial cell morphogenesis is a carbohydrate-dependent process, as it is n
eutralized by specific sugars and antibodies. These findings demonstrate th
at endothelial cell surface carbohydrate recognition event(s) can induce a
signaling cascade leading to the differentiation and angiogenesis of endoth
elial cells.